The FDA says it authorized more than 300 COVID-19 test and collection kits in 2020.
COVID-19 first made waves at the end of 2019 but began to spread throughout the U.S. in the early months of 2020. As the country faced a pandemic, a number of companies developed diagnostics in an effort to slow the spread, with the FDA beginning to issue emergency use authorization (EUA) for the tests in March.